Published in Lancet on December 06, 2003
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol (2011) 5.59
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91
Cervical cancer prevention: new tools and old barriers. Cancer (2010) 2.68
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer (2006) 1.99
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ (2011) 1.72
Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol (2012) 1.57
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev (2008) 1.53
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med (2009) 1.48
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer (2006) 1.43
Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health (2006) 1.39
The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. Br J Cancer (2004) 1.38
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer (2011) 1.38
How to evaluate emerging technologies in cervical cancer screening? Int J Cancer (2009) 1.37
Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol (2006) 1.24
High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer (2007) 1.24
Making sense of information about HPV in cervical screening: a qualitative study. Br J Cancer (2005) 1.24
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
Comparison of non-invasive sampling methods for detection of HPV in rural African women. Sex Transm Infect (2005) 1.22
An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme. Br J Cancer (2004) 1.21
Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer (2010) 1.18
Early detection of cervical carcinomas: finding an overall approach. Dtsch Arztebl Int (2008) 1.16
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ (2006) 1.14
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening. Br J Cancer (2005) 1.12
Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol (2007) 1.12
Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications. J Clin Microbiol (2008) 1.11
HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer (2011) 1.10
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer (2004) 1.08
Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol (2009) 1.08
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer (2010) 1.07
Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol (2007) 1.04
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02
Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3. J Infect Dis (2008) 1.01
Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years. J Gen Intern Med (2016) 1.01
Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol (2009) 0.99
The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc (2005) 0.99
Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix. Indian J Med Res (2012) 0.98
Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia. J Clin Microbiol (2008) 0.96
Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.94
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study. Cancer Med (2014) 0.92
Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer (2008) 0.92
Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer (2007) 0.89
Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods (2013) 0.89
Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infect Agent Cancer (2008) 0.89
An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection. Biomed Res Int (2014) 0.88
Vaccines for cervical cancer. Epidemiol Infect (2006) 0.88
Alternative technologies in cervical cancer screening: a randomised evaluation trial. BMC Public Health (2006) 0.87
Liquid based cytology in cervical cancer screening. BMJ (2007) 0.84
Human papillomavirus testing in cervical cancer screening. Br J Cancer (2005) 0.84
Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results. Clin Epigenetics (2015) 0.83
Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test. Int J Med Sci (2012) 0.83
Women's intentions to receive cervical cancer screening with primary human papillomavirus testing. Int J Cancer (2013) 0.82
Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population. ISRN Oncol (2013) 0.81
Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing. Br J Cancer (2012) 0.81
Postcoital bleeding: a review on etiology, diagnosis, and management. Obstet Gynecol Int (2014) 0.80
Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci (2012) 0.80
New paradigms in cervical cancer prevention: opportunities and risks. BMC Womens Health (2008) 0.79
Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis (2005) 0.79
Atypical squamous cells of undetermined significance: Bethesda classification and association with Human Papillomavirus. Infect Dis Obstet Gynecol (2011) 0.79
Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea. J Cancer Prev (2016) 0.78
Scientific issues related to the cytology proficiency testing regulations. Cytojournal (2006) 0.78
Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate. J Clin Pathol (2006) 0.78
Progress in the development of a cervical cancer vaccine. Ther Clin Risk Manag (2006) 0.78
A new method to address verification bias in studies of clinical screening tests: cervical cancer screening assays as an example. J Clin Epidemiol (2013) 0.78
When to test women for human papillomavirus. BMJ (2006) 0.76
[Risk-adapted multimodal laboratory cervical screening---Pap test of the future?]. Pathologe (2007) 0.76
Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval. BMC Public Health (2016) 0.75
Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall. Int J Clin Exp Pathol (2015) 0.75
The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results. PLoS One (2017) 0.75
Hybrid capture II for high-risk human papillomavirus DNA testing to detect cervical precancerous lesions: A qualitative and quantitative study. Exp Ther Med (2010) 0.75
Are we ready for a paradigm change in cervical cancer screening? Lancet (2003) 0.75
Cytology and human papillomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia. PLoS One (2015) 0.75
Prediction using hierarchical data: Applications for automated detection of cervical cancer. Stat Anal Data Min (2015) 0.75
HPV immunohistochemical testing and cervical dysplasia. Clujul Med (2016) 0.75
Efficacy of a real time optoelectronic device (TruScreen™) in detecting cervical intraepithelial pathologies: a prospective observational study. J Turk Ger Gynecol Assoc (2015) 0.75
Human papillomavirus-related gynecologic neoplasms: screening and prevention. Rev Obstet Gynecol (2008) 0.75
Data are still needed for HPV immunisation programme. BMJ (2005) 0.75
HPV testing may replace Pap smears for primary screening. J Fam Pract (2004) 0.75
Cervical Cancer Screening for the Reluctant - HPV Testing of Air-Dried Vaginal Discharge. Int J Biomed Sci (2006) 0.75
[Cervical cancer screening: past--present--future]. Pathologe (2009) 0.75
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (2008) 8.12
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (1999) 5.81
A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification. J Pathol (1981) 5.61
Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) (2000) 5.19
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology (2011) 5.16
Human papillomavirus testing in primary cervical screening. Lancet (1995) 5.09
Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet (2002) 5.04
Necropsy: a yardstick for clinical diagnoses. Br Med J (1980) 4.71
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med (1997) 4.08
Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol (1997) 3.96
Clinical attitudes to the autopsy. Scott Med J (1978) 3.61
Abnormal plant development and down-regulation of phenylpropanoid biosynthesis in transgenic tobacco containing a heterologous phenylalanine ammonia-lyase gene. Proc Natl Acad Sci U S A (1990) 3.60
Findings in a fox rescued from hounds. Vet Rec (1999) 3.52
Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]. Lancet (1992) 3.48
Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ (2001) 3.48
Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation. Eur J Immunol (1988) 3.47
Survey of medical training in cytopathology carried out by the journal Cytopathology. Cytopathology (2010) 3.32
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem (1995) 3.17
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Trends in hospital necropsy rates: Scotland 1961-74. Br Med J (1977) 3.09
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK. Qual Saf Health Care (2004) 2.85
A prospective study of 1152 hospital autopsies: II. Analysis of inaccuracies in clinical diagnoses and their significance. J Pathol (1981) 2.81
Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77
Cervical sampling devices. BMJ (1996) 2.74
A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol (1997) 2.71
Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. Br J Dermatol (2015) 2.61
The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns (1999) 2.58
Association of hyperglycemia with increased mortality after severe burn injury. J Trauma (2001) 2.55
Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet (1996) 2.47
HPV testing in primary screening of older women. Br J Cancer (1999) 2.44
Indicators of effective cytological sampling of the uterine cervix. Lancet (1989) 2.39
Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35
Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer (1994) 2.35
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Trends in cervical cancer mortality. Lancet (1991) 2.28
Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans (1996) 2.23
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol (2004) 2.16
Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. Eur J Appl Physiol Occup Physiol (1998) 2.16
Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg (2001) 2.13
Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. Oncogene (1992) 2.13
Factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol (2013) 2.11
Stress Responses in Alfalfa (Medicago sativa L.): I. Induction of Phenylpropanoid Biosynthesis and Hydrolytic Enzymes in Elicitor-Treated Cell Suspension Cultures. Plant Physiol (1990) 2.10
Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J Bacteriol (2004) 2.08
The autopsy and clinical diagnosis. J R Coll Physicians Lond (1984) 2.07
Findings in a fox rescued from hounds. Vet Rec (1999) 2.05
Physical activity and colorectal cancer. Am J Epidemiol (2003) 2.04
The pitfalls of measuring changes in smoking habits. Essential NCD Health Intervention Project Team. Trop Doct (2000) 2.03
Dry run. Vet Rec (2000) 2.01
HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer (2006) 1.99
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens (1998) 1.96
Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95
Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol (1988) 1.90
A prospective cohort of American Indian and Alaska Native people: study design, methods, and implementation. Am J Epidemiol (2007) 1.86
Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc (2001) 1.86
A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate. Med Sci Sports Exerc (1983) 1.83
Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect Immun (2001) 1.83
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80
Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A (1986) 1.80
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol (2000) 1.79
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77
The use of cervicography in a primary screening service. Br J Obstet Gynaecol (1991) 1.76
Mexican American and white American school dropouts' drug use, health status, and involvement in violence. Public Health Rep (1990) 1.75
Point of sale tobacco displays and smoking among 14-15 year olds in New Zealand: a cross-sectional study. Tob Control (2009) 1.74
Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Invest (1997) 1.74
Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer (2000) 1.74
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Meeting the challenge of developing and maintaining radical hysterectomy skills. BJOG (2010) 1.71
Onset of blood lactate accumulation and marathon running performance. Int J Sports Med (1981) 1.70
Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect (2003) 1.70
Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut (1998) 1.68
Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer (2013) 1.68
Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med (2000) 1.67
Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet (1988) 1.66
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis. Lancet (1995) 1.65
Needle biopsy of skeletal muscle in the diagnosis of myopathy and the clinical study of muscle function and repair. N Engl J Med (1980) 1.64